Unknown PHASE2 INTERVENTIONAL 2-arm NCT02051907

Clinical Study to Evaluate Safety and Efficacy of KAM1403 Gel to Treat Radiation Dermatitis (kam1403)

A BLIND, CONTROLLED CLINICAL STUDY TO EVALUATE THE EFFICACY AND SAFETY OF KAM1403 GEL TREATMENT IN PATIENTS WITH RADIATION DERMATITIS

Sponsor: Kamedis Ltd.

Conditions Radiation Dermatitis

Interventions KAM1403 Gel aloevera gel

Updated 4 times since 2017 Last updated: Jan 30, 2014 Started: Mar 31, 2014 Primary completion: Mar 31, 2015 Completion: Apr 30, 2015

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE2 trial investigates Radiation Dermatitis and is currently ongoing. Kamedis Ltd. leads this study, which shows 4 recorded versions since 2014 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

4 versions recorded

Sep 2024 — Present [monthly]

Unknown PHASE2
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE2

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status PHASE2
Jan 2017 — Jan 2021 [monthly]

Unknown Status PHASE2

First recorded

Mar 2014

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Kamedis Ltd.

Data source: Kamedis Ltd.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Tel Aviv, Israel